Mark Christianson, Business Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), sold 11,900 shares at $6.74 ($80K) on 2021-06-23, disclosed to the SEC on 2021-06-25.
Open-market sale of $80k NMTC by Business Development Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.74 | 11,300 | $76K | 95.3% |
| 2 | $6.30 | 600 | $4K | 4.7% |
| Total | $6.72 avg | 11,900 | $80K | 100% |
| Filing → |
| NMTC | SELL | 2026-03-16 | $734 | — | Filing → |
| NMTC | SELL | 2026-03-12 | $11K | — | Filing → |
| NMTC | SELL | 2025-09-09 | $22K | — | Filing → |